Chinese herbs combined with Western medicine in the treatment of severe acute respiratory syndrome (SARS)
Citation: Liu X, Zhang M, He L, Li Y. Chinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS). Cochrane Database of Systematic Reviews 2012; (10): CD004882
What is this? The first cases of severe acute respiratory syndrome (SARS) were reported in December 2002. This is an acute respiratory disease caused by a coronavirus and integrated Chinese and Western medicines may have played a role in its successful treatment. Therefore, evidence from studies of these treatments of SARS might help in identifying treatments for COVID-19.
In this Cochrane systematic review, the authors searched for randomized and quasi-randomized trials of Chinese herbs combined with Western medicines versus Western medicines alone for patients with SARS. They did not restrict by language of publication and did their searches in March 2012. They identified 12 randomized and one quasi-randomized trial (total: 640 patients), evaluating 12 different Chinese herbs.
What works: Nothing noted.
What doesn’t work: Chinese herbs combined with Western medicines did not decrease mortality in SARS patients when compared with Western medicines alone.
What’s uncertain: Weak evidence suggests that adding some Chinese herbs to Western medicines may improve symptoms, absorption of pulmonary infiltration and quality of life, and decrease corticosteroid dosage and time in hospital for SARS patients, but this is uncertain.
Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence on the coronavirus (COVID-19) but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about the coronavirus (COVID-19) on the basis of this summary alone.
If you have found this summary helpful, please consider making a donation. If everyone who looked at our COVID-19 resources gave us just £2 per month, it would fund Evidence Aid’s life-saving work.